SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19
http://www.w3.org/2000/01/rdf-schema#comment
"Patients with high levels of tumour cell thymidine phosphorylase expression were significantly associated with a favorable outcome."
xsd:string
http://purl.uniprot.org/uniprot/#_EAC954173043E5310B5926CBEC6AEA32F23EE706E73F7EEC9EB87E5164CEBEE02F0552F0986401E97014F952C1C4D3A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19
http://purl.uniprot.org/uniprot/P19971
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19
http://purl.uniprot.org/uniprot/#_P19971-mappedCitation-17999375
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D89E173F23D4327A44D6C5F487A04C404AAACB16AD4642485A9F3B787F58A0A3FC9FBD6CD15952EA9E125C830DAC8D19